Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer
Qiong-Yuan Chen, Yuxin Chen, Qiu-Yue Han, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects
Xiangyu Wu, Tianhang Li, Rui Jiang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 70
Immunotherapy and immunoevasion of colorectal cancer
Mohammad Al Zein, Mona Boukhdoud, Hadi Shammaa, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 9, pp. 103669-103669
Closed Access | Times Cited: 28
Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
Siyuan Wang, Jiaxin Wang, Yu Xia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Resistance to PD-1/PD-L1 immune checkpoint blockade in advanced non-small cell lung cancer
Lijun Li, Haihong Pu, Xiaoxin Zhang, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 209, pp. 104683-104683
Closed Access | Times Cited: 1
HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 48
HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies
Fabio Morandi, Irma Airoldi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2925-2925
Open Access | Times Cited: 30
Colony-stimulating factor 3 and its receptor promote leukocyte immunoglobulin-like receptor B2 expression and ligands in gastric cancer
Long Wang, Qi Wu, Z. Zhang, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access
Role of FHOD1 in tumor cells and tumor immune microenvironment
Yang Yang, Zhanting Kang, Jinlong Cai, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Cross-Talk Between Tumor Cells Undergoing Epithelial to Mesenchymal Transition and Natural Killer Cells in Tumor Microenvironment in Colorectal Cancer
Ana Vuletić, Katarina Mirjačić Martinović, Nevena Tišma Miletić, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 22
Role of HLA-G in tumors and upon COVID-19 infection
Barbara Seliger
Human Immunology (2024) Vol. 85, Iss. 3, pp. 110792-110792
Open Access | Times Cited: 3
Advances in the study of HLA class Ib in maternal-fetal immune tolerance
Yiran Yang, Wanning Wang, Jing Weng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer
Ana Vuletić, Katarina Mirjačić Martinović, Jelena Spasić
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 54-54
Open Access | Times Cited: 7
HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
Peilong Li, Nan Wang, Yi Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16
Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients
Vladimı́ra Ďurmanová, Miroslav Tedla, Dusan Rada, et al.
Diseases (2024) Vol. 12, Iss. 2, pp. 34-34
Open Access | Times Cited: 2
Pathways and molecules for overcoming immunotolerance in metastatic gastrointestinal tumors
Qixin Gan, Yue Li, Yuejun Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Atractylenolide II combined with Interferon-γ synergistically ameliorates colorectal cancer progression in vivo and in vitro by blocking the NF-kB p65/PD-L1 pathway
Yangsheng Wu, Shijie Dai, YuJia Zhang, et al.
Journal of Cancer (2024) Vol. 15, Iss. 13, pp. 4328-4344
Open Access | Times Cited: 2
The Immunological Contribution of a Novel Metabolism-Related Signature to the Prognosis and Anti-Tumor Immunity in Cervical Cancer
Sihui Yu, Xi Li, Mingjun Ma, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2399-2399
Open Access | Times Cited: 8
Leukocyte immunoglobulin-like receptor B2 overexpression as a promising therapeutic target and noninvasive screening biomarker for colorectal cancer
Qianqian Wang, Lei Zhou, Geng Qin, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 37, pp. 5313-5326
Open Access | Times Cited: 4
The cross-talk between macrophages and tumor cells as a target for cancer treatment
Muhammad Aizaz, Aakif Ullah Khan, Faisal Khan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells
Karthikeyan Subbarayan, Chiara Massa, Sandra Leisz, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 7
Prediction of immunotherapy efficacy and immunomodulatory role of hypoxia in colorectal cancer
Zhuangzhuang Zheng, Chenbin Bian, Huanhuan Wang, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14, pp. 175883592211383-175883592211383
Open Access | Times Cited: 7
Immunomodulatory Potential of Non-Classical HLA-G in Infections including COVID-19 and Parasitic Diseases
Sajad Rashidi, Carmen Vieira, Renu Tuteja, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 257-257
Open Access | Times Cited: 6
Prognostic significance of the immune checkpoint HLA-G/ILT-4 in the survival of patients with gastric cancer
Qiong-Yuan Chen, Wenjun Zhou, Jiang-Gang Zhang, et al.
International Immunopharmacology (2022) Vol. 109, pp. 108798-108798
Closed Access | Times Cited: 6
Human leukocyte antigen‐G in gynaecological tumours
Xinmeng Guo, Jinning Zhang, Jin Shang, et al.
International Journal of Immunogenetics (2023) Vol. 50, Iss. 4, pp. 163-176
Open Access | Times Cited: 3
Low PD‐L1 expression in immune cells predicts the presence of nodal metastasis in early invasive (pT1) colorectal cancer: a novel tool to tailor surgical treatment
Giulia Trucco, Giacomo Maria Benazzo, Alessia Andrea Ricci, et al.
Histopathology (2023) Vol. 83, Iss. 1, pp. 126-136
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top